Skip to main content

Germany

Asia’s next big growth market

Asia-Pacific is still very much the place to be in insurance terms but as Jenni Marsh reports the less traditional markets, outside of China and Japan, are expected to be the real growth stories in the coming years.

Mandatory commission – an necessary evil?

Rumors of mandatory commission disclosure have plagued the market since the start of the year but as the European Commission confirms brokers fears Francesca Nyman assesses the impact on European brokers.

A mutual future?

Regulations like Solvency II will have a significant impact on mutuals across Europe. Francesca Nyman asks whether the model will survive.

UK insurers face capital hike under RMS v11

UK insurers may see increases of up to 97% in their capital requirement for catastrophe exposures under Solvency II rules when making calculations under the new RMS model version 11, with French and German insurers facing similar though not quite so…

MGA Dual expands with new Austrian office

Dual Group, the underwriting arm of Hyperion Insurance Group, has announced that Dual Austria will open its doors in Vienna on 1 July fronted by liability specialist Hannes Puchner.

Germany 'must open up' to global insurance market

The Eurozone crisis and the export-led boom in German industry mean that Germany's insurance buyers must look to markets outside their own borders for insurance solutions, according to Jan Blumenthal, Lloyd's general representative for Germany.

Europa to delist following acquisition

Talanx International AG and Japanese insurer Meiji Yasuda Life Insurance Company have successfully closed their joint acquisition of the Polish Europa Insurance Group.

Talanx enters Indian market via joint venture

Talanx-owned insurer HDI-Gerling will enter the Indian market through a joint venture with Indian firm NBFC Magma Fincorp after a three-year bid to gain a licence for the region.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here